Figure 4
Loss of endogenous Bcl-2 does not affect the enhanced proliferation of Eμ-myc transgenic B lymphoid cells. Donor-derived pro-B cells (Ly5.2+ B220+ sIg− c-Kit+) and pre-B cells (Ly5.2+ B220+ sIg− c-Kit−) were purified by multiparameter cell sorting from the bone marrow of mice reconstituted with wt, bcl-2−/−, Eμ-myc, and Eμ-myc/bcl-2−/− cells. The purified cells were then permeabilized and stained with PI, and their DNA content was analyzed by flow cytometry. The average percentages of cells in the G0/G1 and S/G2/M phases, obtained by manual gating, are indicated in the top right corners of the histograms. Results are representative of 3 to 4 independent experiments from 3 to 5 mice of each genotype.

Loss of endogenous Bcl-2 does not affect the enhanced proliferation of Eμ-myc transgenic B lymphoid cells. Donor-derived pro-B cells (Ly5.2+ B220+ sIg c-Kit+) and pre-B cells (Ly5.2+ B220+ sIg c-Kit) were purified by multiparameter cell sorting from the bone marrow of mice reconstituted with wt, bcl-2−/−, Eμ-myc, and Eμ-myc/bcl-2−/− cells. The purified cells were then permeabilized and stained with PI, and their DNA content was analyzed by flow cytometry. The average percentages of cells in the G0/G1 and S/G2/M phases, obtained by manual gating, are indicated in the top right corners of the histograms. Results are representative of 3 to 4 independent experiments from 3 to 5 mice of each genotype.

Close Modal

or Create an Account

Close Modal
Close Modal